VEGFR — Drug Target

All drugs that target VEGFR — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

tyrosine kinase inhibitor · VEGF inhibitor

Phase 3 pipeline (2)

• OTX-TKI (axitinib implant) · Ocular Therapeutix, Inc. · tyrosine kinase inhibitor · Oncology
  OTX-TKI (axitinib implant) is a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors.
• Vorolanib Tablets+Everolimus · Peking University Cancer Hospital & Institute · tyrosine kinase inhibitor · Oncology
  Vorolanib is a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFRs), and Everolimus is an mTOR inhibitor.

Phase 1 pipeline (1)

• AAV2-sFLT01 · Genzyme, a Sanofi Company · VEGF inhibitor · Oncology
  VEGF inhibitor